Hepatitis C, a global issue: access to care and new therapeutic and preventive approaches in resource-constrained areas.


With the advent of all oral direct-acting antiviral drugs with a broad range of genotypic activity and a low incidence of side effects, we are entering an exciting new era in the therapeutics of hepatitis C virus (HCV). However, it is not yet clear who will benefit from these innovations: Will the advantages be limited to HCV patients in industrialized… (More)
DOI: 10.1055/s-0034-1371082


2 Figures and Tables

Blog articles referencing this paper

Slides referencing similar topics